Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evocalcet vs cinacalcet in hemodialysis patients with secondary hyperparathyroidism
CTR20200303Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ASP7991 in secondary hyperparathyroidism (SHPT), chronic kidney disease (CKD), end-stage kidney disease (ESKD), sponsored by Kyowa Kirin. Started Mar 2020; status: completed.
02
Drugs
ASP7991
03
Conditions
secondary hyperparathyroidism (SHPT)chronic kidney disease (CKD)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on CTR20200303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200303.